How effectively do we apply first-line treatment in overactive bladder?

Area of Science:

• Urology
• Pelvic Health
• Behavioral Medicine

Background:

• Overactive bladder (OAB) significantly impacts quality of life.
• Patients refractory to initial drug therapy often require further treatment options.

Purpose of the Study:

• To evaluate the effectiveness of combining behavioral therapy (BT), drug therapy, and pelvic floor muscle training (PFMT) in OAB patients unresponsive to drug therapy.
• To compare this combined approach against BT and drug therapy alone.

Main Methods:

• A prospective randomized controlled trial included 70 female patients (18-65 years) with wet-type OAB.
• Patients received either BT + drug therapy (control) or BT + PFMT + drug therapy (active) for 12 weeks.
• Outcomes measured included OAB scores, ICIQ-SF, frequency, and nocturia.

Main Results:

• The active therapy group showed a significant decrease in OAB scores (p<0.01), unlike the control group (p=0.06).
• Both groups improved in ICIQ-SF scores and nocturia, but frequency reduction was significant only in the active group (p<0.01).
• Patient satisfaction and dryness rates were higher in the active therapy group (34.3% vs 10%; 31.25% vs 13.3%).

Conclusions:

• Combining BT, drug therapy, and PFMT is effective for OAB patients resistant to drug therapy.
• This multimodal approach reduces OAB symptoms and may decrease the need for invasive treatments.
• PFMT offers a valuable addition to standard OAB treatment protocols.